Annual report pursuant to Section 13 and 15(d)

Stockholders' equity - Schedule of warrants or rights (Detail)

v3.21.2
Stockholders' equity - Schedule of warrants or rights (Detail) - $ / shares
12 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Equity [Abstract]    
Outstanding, beginning of period 145,424 38,329
Granted 559,162 241,716
Exercised (559,162) (27,526)
Cashless exercise (38,329) (107,095)
Outstanding, ending of period 107,095 145,424
Exercise price of class of warrants or rights outstanding $ 29.48 $ 82.50
Granted 3.09 10.50
Exercised 3.10 10.50
Cashless exercise 82.50 10.50
Exercise price of class of warrants or rights outstanding and excercisable $ 10.50 $ 29.48